EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Randomized, Blinded, Placebo‐Controlled Crossover Study of the Pharmacokinetics and Pharmacodynamics of Naloxone, Naltrexone, and Nalmefene in Methadone‐Sedated Working Dogs

Travis Mills, Mary A Robinson iD, Ciara Barr, Darko Stefanovski iD, Youwen You iD, Rachel Proctor, Kasey Seizova, Amritha Mallikarjun, Cynthia M Otto

Journal of Veterinary Pharmacology and Therapeutics · 2025

DOI: 10.1111/jvp.13515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, 2025. Verfasst von Travis Mills und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Methadone, Naloxone, Naltrexone, Narcotic Antagonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Defense Health Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A randomized, blinded, placebo‐controlled crossover study was performed with eight professional working dogs to evaluate the pharmacokinetics and pharmacodynamics of three opioid reversal agents. Following sedation with 1 mg kg −1 methadone HCl IV, dogs were randomly assigned to receive naloxone, naltrexone, or nalmefene at 0.1 mg kg −1 IM, or saline (0.1 mL kg −1 ). Sedation scores and vital signs were obtained for 6 h, and blood samples were obtained for 72 h. Across all groups and phases, the mean sedation score prior to methadone was 0.93/14, and prior to reversal/placebo was 11.45/14. Mean sedation scores 1 min post reversal/placebo were 7.6, 7.4, 8.1, and 10.6; and at 5 min were 2.2, 1.9, 1.9, and 11.8 for nalmefene, naloxone, naltrexone, and saline, respectively. Dogs with a sedation score ≥ 10/14 at 20 min after reversal/placebo were administered 0.1 mg kg −1 of naloxone IM and included all dogs that received saline. The reversal agents significantly decreased sedation scores within 5 min ( p < 0.001) and reversal was maintained for the duration of the study. A previously undetected slower terminal elimination phase was observed for all analytes between 24 and 72 h; however, future studies with additional time points between 6 and 24 h are needed to generate pharmacokinetic estimates for this phase. These reversal agents may be useful for treating sedation in professional working dogs exposed to opioids prior to seeking veterinary care. Pharmacological differences between methadone and higher potency opioids (fentanyl and its derivatives) preclude interpretation of these findings to non‐methadone opioids, and further studies are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethadoneNaloxoneNaltrexoneNarcotic AntagonistsAnimalsDogsAnalgesics, OpioidCross-Over Studies

Stichwörter der Autor:innen

drug detection dogmu antagonistnarcotizationopioidreversal

Substanzen

Analgesics, OpioidMethadonenalmefeneNaloxoneNaltrexoneNarcotic Antagonists

Autor:innen und Institutionen

  • Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Clinical Studies - New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, Pennsylvania, USA.
  • PA Equine Toxicology and Research Laboratory, West Chester, Pennsylvania, USA.
  • Penn Vet Working Dog Center, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Mary A Robinson, Darko Stefanovski, Youwen You

Förderung

  • Defense Health Agency

Zitieren

APA

Mills, T., Robinson, M. A., Barr, C., Stefanovski, D., You, Y., Proctor, R., Seizova, K., Mallikarjun, A., & Otto, C. M. (2025). A Randomized, Blinded, Placebo‐Controlled Crossover Study of the Pharmacokinetics and Pharmacodynamics of Naloxone, Naltrexone, and Nalmefene in Methadone‐Sedated Working Dogs. Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.13515

Vancouver

Mills T, Robinson MA, Barr C, Stefanovski D, You Y, Proctor R, et al. A Randomized, Blinded, Placebo‐Controlled Crossover Study of the Pharmacokinetics and Pharmacodynamics of Naloxone, Naltrexone, and Nalmefene in Methadone‐Sedated Working Dogs. Journal of Veterinary Pharmacology and Therapeutics. 2025. doi:10.1111/jvp.13515

BibTeX
@article{Mills2025,
  author = {Mills, Travis and Robinson, Mary A and Barr, Ciara and Stefanovski, Darko and You, Youwen and Proctor, Rachel and Seizova, Kasey and Mallikarjun, Amritha and Otto, Cynthia M},
  title = {A Randomized, Blinded, Placebo‐Controlled Crossover Study of the Pharmacokinetics and Pharmacodynamics of Naloxone, Naltrexone, and Nalmefene in Methadone‐Sedated Working Dogs},
  journal = {Journal of Veterinary Pharmacology and Therapeutics},
  year = {2025},
  doi = {10.1111/jvp.13515}
}
Kostenlos starten →